These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 16160618

  • 1. Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?
    Mosyagin I, Cascorbi I, Schaub R, Krüger T, Dettling M.
    J Clin Psychopharmacol; 2005 Oct; 25(5):435-40. PubMed ID: 16160618
    [Abstract] [Full Text] [Related]

  • 2. Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6.
    Dettling M, Sachse C, Müller-Oerlinghausen B, Roots I, Brockmöller J, Rolfs A, Cascorbi I.
    Pharmacopsychiatry; 2000 Nov; 33(6):218-20. PubMed ID: 11147929
    [Abstract] [Full Text] [Related]

  • 3. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.
    Athanasiou MC, Dettling M, Cascorbi I, Mosyagin I, Salisbury BA, Pierz KA, Zou W, Whalen H, Malhotra AK, Lencz T, Gerson SL, Kane JM, Reed CR.
    J Clin Psychiatry; 2011 Apr; 72(4):458-63. PubMed ID: 20868635
    [Abstract] [Full Text] [Related]

  • 4. Clozapine induced agranulocytosis: hypothesis on immune-mediated pathogenesis and the role of haematopoietic growth factors.
    Faber HJ, Smit AJ, van de Loosdrecht AA.
    Neth J Med; 1999 Aug; 55(2):86-7. PubMed ID: 10474279
    [No Abstract] [Full Text] [Related]

  • 5. Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis.
    Mosyagin I, Dettling M, Roots I, Mueller-Oerlinghausen B, Cascorbi I.
    J Clin Psychopharmacol; 2004 Dec; 24(6):613-7. PubMed ID: 15538122
    [Abstract] [Full Text] [Related]

  • 6. Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry.
    Dettling M, Schaub RT, Mueller-Oerlinghausen B, Roots I, Cascorbi I.
    Pharmacogenetics; 2001 Mar; 11(2):135-41. PubMed ID: 11266078
    [Abstract] [Full Text] [Related]

  • 7. Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C.
    McKnight C, Guirgis H, Votolato N.
    Am J Psychiatry; 2011 Oct; 168(10):1120. PubMed ID: 21969051
    [No Abstract] [Full Text] [Related]

  • 8. N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopenia.
    Combs MD, Perry PJ, Bever KA.
    Pharmacotherapy; 1997 Oct; 17(6):1300-4. PubMed ID: 9399615
    [Abstract] [Full Text] [Related]

  • 9. How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?
    Verbelen M, Lewis CM.
    Pharmacogenomics; 2015 Oct; 16(9):915-7. PubMed ID: 26122865
    [No Abstract] [Full Text] [Related]

  • 10. Clozapine-induced agranulocytosis and its genetic determinants.
    Opgen-Rhein C, Dettling M.
    Pharmacogenomics; 2008 Aug; 9(8):1101-11. PubMed ID: 18681784
    [Abstract] [Full Text] [Related]

  • 11. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
    Güzelcan Y, Scholte WF.
    Tijdschr Psychiatr; 2006 Aug; 48(4):295-302. PubMed ID: 16955993
    [Abstract] [Full Text] [Related]

  • 12. White blood cell monitoring during long-term clozapine treatment.
    Cohen D, Monden M.
    Am J Psychiatry; 2013 Apr; 170(4):366-9. PubMed ID: 23545791
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mitchell B. Balter Award. Human leukocyte antigen-A1 predicts a good therapeutic response to clozapine with a low risk of agranulocytosis in patients with schizophrenia.
    Lahdelma L, Ahokas A, Andersson LC, Suvisaari J, Hovatta I, Huttunen MO, Koskimies S.
    J Clin Psychopharmacol; 2001 Feb; 21(1):4-7. PubMed ID: 11199946
    [Abstract] [Full Text] [Related]

  • 15. Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis.
    Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Müller DJ, Putkonen A, Repo-Tiihonen E, Hallikainen T, Yağcıoğlu AE, Tiihonen J, Kennedy JL, Meltzer HY.
    Mol Psychiatry; 2014 Apr; 19(4):403-5. PubMed ID: 23752246
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.